The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preliminary outcomes of a primary care-based skin cancer screening program.
 
Laura Ferris
Consulting or Advisory Role - AstraZeneca (I); Bristol-Myers Squibb (I); Castle Biosciences; Celgene (I); DermTech; Lilly; Lilly (I); Merck (I); Pfizer
Research Funding - Abbvie (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); Castle Biosciences (Inst); Celgene (Inst); Centocor Ortho Biotech (Inst); DermTech (Inst); GlaxoSmithKline (Inst); Janssen Biotech (Inst); LEO Pharma (Inst); MedImmune (I); MedImmune (Inst); Novartis (Inst); Pfizer (Inst); Regeneron (Inst); VentiRx (I)
 
Melissa Saul
No Relationships to Disclose
 
Yan Lin
No Relationships to Disclose
 
Martin A. Weinstock
No Relationships to Disclose
 
Alan Geller
No Relationships to Disclose
 
Francis Solano
No Relationships to Disclose
 
Erica Bromberg Neuren
No Relationships to Disclose
 
John M. Kirkwood
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Genentech; GreenPeptide; Roche
Research Funding - Merck (Inst); Prometheus (Inst)